Mangkalaphiban, Kotchaphorn
Fu, Lianwu
Du, Ming
Thrasher, Kari http://orcid.org/0000-0003-0281-1686
Keeling, Kim M. http://orcid.org/0000-0003-0471-5858
Bedwell, David M. http://orcid.org/0000-0002-6605-818X
Jacobson, Allan http://orcid.org/0000-0002-5661-3821
Funding for this research was provided by:
Cystic Fibrosis Foundation (CFFKOROST20GO, BEDWEL19G0, 858345, BEDWEL19G0, 858345)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (1R35GM122468)
Article History
Received: 1 August 2023
Accepted: 6 March 2024
First Online: 20 March 2024
Competing interests
: A.J. is co-founder, director, and consultant for PTC Therapeutics Inc. D.B., K.M., L.F., M.D., K.T., and K.K. declare no competing interests.